首页> 外国专利> PROCESS FOR PRODUCING PHARMACEUTICAL COMPOSITIONS CONTAINING ALPHA-BRACKET-3,4-DIHYDROXYPHENYL-BRACKET CLOSED-BETA-METHYL-AMINO-ETHANOL AND AND AN AGENT OF ADRENERG NEURON-BLOCCING ACTIVITY

PROCESS FOR PRODUCING PHARMACEUTICAL COMPOSITIONS CONTAINING ALPHA-BRACKET-3,4-DIHYDROXYPHENYL-BRACKET CLOSED-BETA-METHYL-AMINO-ETHANOL AND AND AN AGENT OF ADRENERG NEURON-BLOCCING ACTIVITY

机译:制备包含α-支架-3,4-二羟基苯酚-支架,封闭式-甲基-氨基-乙醇和ADRENERG的活性成分的药物组合物的方法

摘要

Mixing of an aqueous suspension of a catecholamine in the presence of disodium edetate and sodium metabisulphite with active charcoal at a pH of 4.5 under nitrogen and filtration results in a catecholamine solution with less than 1 ppm heavy metals, from which the catecholamine is precipitated and converted into a water-soluble complex with a thiol derivative of an alpha -amino acid by addition of a 0.5 - 5 % by weight aqueous solution of the thiolic compound together with an acid or a compound with an acid reaction, and subsequent addition of a base to a pH of 6.0 - 7.5. The prepared solutions are, owing to the absence of ferric ions and borate ions, stable even under aerobic conditions and are used as eye drops for the treatment of glaucoma.
机译:在乙二胺四乙酸二钠和偏亚硫酸氢钠存在下,儿茶酚胺的水悬浮液与活性炭在pH为4.5的氮气氛下混合并过滤,得到一种儿茶酚胺溶液,重金属含量低于1 ppm,儿茶酚胺从中沉淀并转化通过将0.5-5重量%的硫醇化合物的水溶液与酸或具有酸反应的化合物一起添加,并随后添加碱,将其与α-氨基酸的硫醇衍生物形成水溶性络合物。达到pH 6.0-7.5。由于不存在三价铁离子和硼酸根离子,因此制备的溶液即使在有氧条件下也稳定,并用作治疗青光眼的滴眼剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号